Atactic Technologies Inc. produces and markets molecular products for use in life science research applications. Atactic developed a suite of novel technologies to produce oligonucleotide mixes, long DNA sequences, and microfluidic array products containing large numbers of customer defined sequences at a significantly reduced cost than conventional technologies can provide